Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19
Clinical trial NCT04362189 · TERMINATED
Trial details
- NCT number
- NCT04362189
- Sponsor
- Hope Biosciences Research Foundation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-09-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.